Castle Biosciences Dirección
Dirección controles de criterios 4/4
El CEO de Castle Biosciences es Derek Maetzold , nombrado en Sep 2007, tiene una permanencia de 17.17 años. compensación anual total es $1.61M, compuesta por 42.7% salario y 57.3% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.43% de las acciones de la empresa, por valor de $11.92M. La antigüedad media del equipo directivo y de la junta directiva es de 4.3 años y 4 años, respectivamente.
Información clave
Derek Maetzold
Chief Executive Officer (CEO)
US$1.6m
Compensación total
| Porcentaje del salario del CEO | 42.7% |
| Permanencia del CEO | 17.2yrs |
| Participación del CEO | 1.4% |
| Permanencia media de la dirección | 4.3yrs |
| Promedio de permanencia en la Junta Directiva | 4yrs |
Actualizaciones recientes de la dirección
Recent updates
Are Investors Undervaluing Castle Biosciences, Inc. (NASDAQ:CSTL) By 49%?
Oct 15
Castle Biosciences: Inflection Into Profitability
Aug 16Upgrade: Analysts Just Made A Meaningful Increase To Their Castle Biosciences, Inc. (NASDAQ:CSTL) Forecasts
Aug 11Castle Biosciences, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
Aug 08Castle Biosciences, Inc.'s (NASDAQ:CSTL) 28% Share Price Surge Not Quite Adding Up
Aug 04Is Castle Biosciences (NASDAQ:CSTL) A Risky Investment?
Jul 12Castle Biosciences, Inc.'s (NASDAQ:CSTL) P/S Is On The Mark
Apr 30Investors Appear Satisfied With Castle Biosciences, Inc.'s (NASDAQ:CSTL) Prospects
Jan 27Castle Biosciences (NASDAQ:CSTL) Is In A Good Position To Deliver On Growth Plans
Oct 31Earnings Working Against Castle Biosciences, Inc.'s (NASDAQ:CSTL) Share Price Following 36% Dive
Jun 13Analysts Just Published A Bright New Outlook For Castle Biosciences, Inc.'s (NASDAQ:CSTL)
Aug 14Castle Biosciences Q2 2022 Earnings Preview
Aug 08Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$6m |
| Jun 30 2024 | n/a | n/a | -US$3m |
| Mar 31 2024 | n/a | n/a | -US$31m |
| Dec 31 2023 | US$2m | US$686k | -US$57m |
| Sep 30 2023 | n/a | n/a | -US$76m |
| Jun 30 2023 | n/a | n/a | -US$89m |
| Mar 31 2023 | n/a | n/a | -US$72m |
| Dec 31 2022 | US$8m | US$660k | -US$67m |
| Sep 30 2022 | n/a | n/a | -US$53m |
| Jun 30 2022 | n/a | n/a | -US$44m |
| Mar 31 2022 | n/a | n/a | -US$52m |
| Dec 31 2021 | US$7m | US$625k | -US$31m |
| Sep 30 2021 | n/a | n/a | -US$30m |
| Jun 30 2021 | n/a | n/a | -US$23m |
| Mar 31 2021 | n/a | n/a | -US$15m |
| Dec 31 2020 | US$5m | US$550k | -US$10m |
| Sep 30 2020 | n/a | n/a | -US$3m |
| Jun 30 2020 | n/a | n/a | US$7m |
| Mar 31 2020 | n/a | n/a | US$6m |
| Dec 31 2019 | US$4m | US$770k | US$3m |
| Sep 30 2019 | n/a | n/a | US$4m |
| Jun 30 2019 | n/a | n/a | -US$6m |
| Mar 31 2019 | n/a | n/a | -US$8m |
| Dec 31 2018 | US$791k | US$410k | -US$10m |
Compensación vs. Mercado: La compensación total de Derek($USD1.61M) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD3.17M).
Compensación vs. Ingresos: La compensación de Derek ha sido consistente con los resultados de la empresa en el último año.
CEO
Derek Maetzold (62 yo)
17.2yrs
Permanencia
US$1,605,984
Compensación
Mr. Derek J. Maetzold founded Castle Biosciences Incorporated in September 2007 and serves as its President, Chief Executive Officer and Director since September 2007. He serves as the Director at AltheaDx...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder | 17.2yrs | US$1.61m | 1.43% $ 11.9m | |
| CFO & Treasurer | 6.9yrs | US$880.25k | 0.11% $ 918.8k | |
| Chief Operating Officer | 4.3yrs | US$828.48k | 0.48% $ 4.0m | |
| Chief Commercial Officer | 4.3yrs | US$829.10k | 0.20% $ 1.7m | |
| Vice President of Investor Relations & Corporate Affairs | no data | sin datos | sin datos | |
| Vice President of Sales | 2.4yrs | sin datos | sin datos | |
| VP of Human Resources & Executive Director of Human Resources | 4.3yrs | sin datos | sin datos | |
| Senior Vice President of Medical | 1.5yrs | sin datos | sin datos | |
| Company Secretary | no data | US$1.69m | sin datos |
4.3yrs
Permanencia media
62yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de CSTL se considera experimentado (4.3 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder | 17.2yrs | US$1.61m | 1.43% $ 11.9m | |
| Independent Chairman of the Board | 12.2yrs | US$305.95k | 0.078% $ 651.1k | |
| Independent Director | 5.9yrs | US$289.20k | 0.047% $ 396.2k | |
| Independent Director | 3.5yrs | US$279.20k | 0.062% $ 513.7k | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 3.3yrs | US$276.70k | 0.049% $ 410.9k | |
| Independent Director | 4.6yrs | US$285.45k | 0.047% $ 396.2k | |
| Independent Director | 3.3yrs | US$274.20k | 0.066% $ 553.9k | |
| Independent Director | less than a year | sin datos | sin datos |
4.0yrs
Permanencia media
62.5yo
Promedio de edad
Junta con experiencia: La junta directiva de CSTL se considera experimentada (4 años de antigüedad promedio).